Log In
Print
BCIQ
Print
Print this Print this
 

Zomig, zolmitriptan

Also known as: Zomig rapimelt

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSerotonin (5-HT1B) and serotonin (5-HT1D) receptor agonist
Molecular Target Serotonin (5-HT1B) receptor ; Serotonin (5-HT1D) receptor
Mechanism of ActionSerotonin (5-HT1B) receptor agonist; Serotonin (5-HT1D) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMigraine
Indication DetailsTreat acute migraine; Treat menstrual migraine; Treat migraine; Treat migraine in adolescents; Treat moderate or severe migraine
Regulatory Designation

Partner

Impax Laboratories Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$130.0M

$130.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today